Financial Performance
5Y price score: 129
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 142.5%
US$ Per
Share
By default your notes are visible only to you.
142.1
52-week range
207.7
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
4.2 %
Dividend Yield TTM
3 %
Market cap $
$ 302,246
Price / Earnings TTM
27.9
Price / Book TTM
(35.3)
PEG TTM
(3.6)
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
19.2 %
117.2 %
142.5 %
Free cash flow per share growth
66.8 %
15.8 %
53.5 %
Earnings per share growth
(7.7) %
40.7 %
64.3 %
Founded: 1,847
Employees: 83,100
Business Summary:
Latest Earnings Call Takeaways
2026 Q2 (Jul 22, 2026)
1) Strong Q2 Performance
- Q2 net revenue grew by 8% organically and 11% in operating income.
- Adjusted diluted EPS reached $2.20, reflecting a 15% increase in dollar terms.
- Smoke-Free Products drove high single-digit volume growth and double-digit revenue growth.
- IQOS adjusted in-market sales volume increased by 5%, with strong performance in markets excluding Japan and Poland.
2) Segment Results and Growth Drivers
- Total shipment volumes increased by 2.5% in Q2, with smoke-free products growing by 7.5%.
- Combustible products also performed well, with Q2 cigarette shipments up 1.1%.
- H1 organic net revenue growth reached 5.3%, with adjusted operating income increasing by 6.1%.
- Strong pricing contributed 5.9 points to H1 organic growth, with combustible pricing at 9.2%.
3) Challenges and Headwinds
- Transitory headwinds from excise increases in Japan and flavor bans in Poland impacted IQOS growth.
- Competitive dynamics in the U.S. nicotine pouch market remain uneven, affecting ZYN's growth.
- The company anticipates continued volatility in Japan due to pricing adjustments and consumer behavior changes.
4) Operational Plans and Investments
- PMI plans to accelerate U.S. investments in the second half of the year, focusing on ZYN and preparing for the launch of IQOS ILUMA.
- New product variants for ZYN, including lower nicotine options, are expected to enhance market positioning.
- The company aims for a $2 billion cost savings target by 2026, with over $300 million achieved in H1.
5) Guidance and Outlook
- PMI maintains its full-year guidance for organic net revenue growth of 5% to 7% and adjusted diluted EPS growth of 7.5% to 9.5%.
- The company expects stable to slightly positive total shipment volumes for the year, with a more moderate decline in cigarette volumes.
- Q3 adjusted diluted EPS is forecasted between $2.20 to $2.25, reflecting a challenging tax rate comparison.
Bottom line: PMI's strong Q2 results and robust smoke-free growth position the company well for continued investment and shareholder returns, despite facing some market headwinds and competitive challenges. The focus on innovation and strategic investments in the U.S. market is expected to drive future growth.
Annual Reports, Presentations And IR Contacts
Go to the websitePhilip Morris International Inc. — Financial Overview, Stock Price, Market Cap
Philip Morris International Inc. is a company. Founded in 1847. As of August 26, 2026, the company's market capitalization is $302245651200 with a current stock price of $193.92.